Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank31
3Y CAGR-45.9%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-45.9%/yr
vs -42.1%/yr prior
Acceleration
-3.8pp
Decelerating
Percentile
P31
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.88 | -86.6% |
| 2023 | 6.58 | -86.8% |
| 2022 | 49.90 | +791.4% |
| 2021 | 5.60 | -60.6% |
| 2020 | 14.20 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 49.80 | +3608.6% |
| 2016 | 1.34 | -97.7% |
| 2015 | 57.75 | - |